Stroke, Vol 20, 809-814, Copyright © 1989 by American Heart Association
LR Ment, WB Stewart, OA Petroff and CC Duncan
During perinatal asphyxia, cerebral blood flow is markedly reduced in the
gray and white matter of the telencephalon. Since previous work has
implicated prostaglandins in the control of blood flow, we tested the
hypothesis that a thromboxane synthesis inhibitor would improve cerebral
blood flow and blunt the metabolic alterations that accompany asphyxia.
Forty-three newborn beagles 2-7 days old were anesthetized, ventilated, and
randomized to insult (5 minutes of asphyxia) or no insult and received
treatment with either the thromboxane synthesis inhibitor CGS 13080
(CIBA-GEIGY Corp.) (0.06 mg/kg/hr i.v. infusion) or saline. Cerebral blood
flow was measured in 25 pups. Pups received treatment 30 minutes before
insult or no insult. In pups randomized to insult and receiving saline,
cerebral blood flow increased during insult in the medulla but decreased
elsewhere. Pups randomized to insult and treated with thromboxane synthesis
inhibitor had increased cerebral blood flow during insult in all cerebral
regions studied. In addition, these pups experienced a significantly higher
incidence of intraventricular hemorrhage than did pups randomized to insult
and receiving saline. In other experiments with 18 pups, brain extracts
were prepared for proton nuclear magnetic resonance spectral analysis of
high-energy phosphorylated compounds and lactate levels. In pups exposed to
insult and receiving saline, mean +/- SD phosphocreatine concentration fell
from 1.9 +/- 0.1 to 0.4 +/- 0.1 mmol/kg, lactate concentration increased
from 2.0 +/- 0.5 to 3.3 +/- 0.4 mmol/kg, and the calculated pH fell 0.8
units. There were no differences between groups.(ABSTRACT TRUNCATED AT 250
WORDS)
ARTICLES
Thromboxane synthesis inhibitor in a beagle pup model of perinatal asphyxia
Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06510.
This article has been cited by other articles:
![]() |
X. Hou, F. Gobeil Jr., A. M. Marrache, C. Quiniou, S. Brault, D. Checchin, S. G. Bernier, F. Sennlaub, J.-S. Joyal, D. Abran, et al. Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R928 - R935. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Beauchamp, A. K. Martinez-Bermudez, F. Gobeil Jr., A. M. Marrache, X. Hou, G. Speranza, D. Abran, C. Quiniou, P. Lachapelle, J. Roberts II, et al. Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy J Appl Physiol, June 1, 2001; 90(6): 2279 - 2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Najarian, P. Hardy, X. Hou, J. Lachapelle, A. Doke, F. Gobeil Jr., M.-S. Roy, P. Lachapelle, D. R. Varma, and S. Chemtob Preservation of neural function in the perinate by high PGE2 levels acting via EP2 receptors J Appl Physiol, August 1, 2000; 89(2): 777 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hou, F. Gobeil Jr, K. Peri, G. Speranza, A. M. Marrache, P. Lachapelle, J. Roberts II, D. R. Varma, S. Chemtob, and E. F. Ellis Augmented Vasoconstriction and Thromboxane Formation by 15-F2t-Isoprostane (8-Iso-Prostaglandin F2{alpha}) in Immature Pig Periventricular Brain Microvessels • Editorial Comment Stroke, February 1, 2000; 31(2): 516 - 524. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |